← Browse by Condition
Medical Condition

idh1 r132h

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06161974 Phase 2
Recruiting

Study of Olutasidenib and Temozolomide in HGG

Enrollment
60 pts
Location
United States, Austr...
Sponsor
Rigel Pharmaceuticals
View Trial →